References
- Ahren, B. 2005. Type 2 diabetes, insulin secretion and betacell mass. Curr. Mol. Med. 5(3): 275-286.
- Ali-Shtayeh, M. S., Yaniv, Z., Mahajna, J. 2000. Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants. J. Ethnopharmacol. 73(1-2): 221-232.
- Bouche, C., Serdy, S., Kahn, C. R., Goldfine, A. B. 2004. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr. Rev. 25(5): 807-830.
- Chakraborty, C. 2006. Biochemical and molecular basis of insulin resistance. Curr. Protein Pept. Sci. 7(2): 113-121.
- Chang, L., Chiang, S. H., Saltiel, A. R. 2004. Insulin signaling and the regulation of glucose transport. Mol. Med. 10(7-12): 65-71.
- Chaturvedi, N. 2007 The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res. Clin. Pract. 76 1 S3-12.
- Chen, D., Wang, M. W. 2005. Development and application of rodent models for type 2 diabetes. Diabetes Obes. Metab. 7(4): 307-317.
- Cicero, A. F., Derosa, G., Gaddi, A. 2004. What do herbalists suggest to diabetic patients in order to improve glycemic control? Evaluation of scientific evidence and potential risks. Acta Diabetol. 41(3): 91-98.
- Cnop, M., Welsh, N., Jonas, J. C., Jorns, A., Lenzen, S., Eizirik, D. L. 2005. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 Suppl 2 S97-107.
- Dafni, A., Yaniv, Z., Palevitch, D. 1984. Ethnobotanical survey of medicinal-plants in Northern Israel. J. Ethnopharmacol. 10(3): 295-310.
- Devendra, D., Liu, E., Eisenbarth, G. S. 2004. Type 1 diabetes: recent developments. Br. Med. J. 328(7442): 750-754.
- Frame, S., Zheleva, D. 2006. Targeting glycogen synthase kinase-3 in insulin signalling. Expert Opin. Ther. Targets 10(3): 429-444.
- Frost, S. C., Lane, M. D. 1985. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J. Biol. Chem. 260(5): 2646-2652.
- Giorgino, F., Laviola, L., Leonardini, A. 2005. Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies. Diabetes Res. Clin. Pract. 68 Suppl1 S22-S29.
- Hamdan, I. I., Afifi, F. U. 2004. Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. J. Ethnopharmacol. 93(1): 117-121.
- Henriksen, E. J., Dokken, B. B. 2006. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Curr. Drug Targets 7(11): 1435-1441.
- Ivorra, M. D., Paya, M., Villar, A. 1989. A review of natural products and plants as potential antidiabetic drugs. J. Ethnopharmacol. 27(3): 243-275.
- Kanter, Y., Teicher, D., Wiener, F., Lesman, T., Mandelbaum, A. 1983. The response to oral glucose among diabetic and normal rats primed with Poterium spinosum extracts. Is. J. Med. Sci. 19: 304-308.
- Kraemer, F. B., Shen, W. J. 2002. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J. Lipid Res. 43(10): 1585-1594.
- Kralisch, S., Klein, J., Lossner, U., Bluher, M., Paschke, R., Stumvoll, M., Fasshauer, M. 2005. Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Mol. Cell Endocrinol. 240(1-2), 43-49.
- Kulkarni, R. N., Wang, Z. L., Wang, R. M., Hurley, J. D., Smith, D. M., Ghatei, M. A., Withers, D. J., Gardiner, J. V., Bailey, C. J., Bloom, S. R. 1997. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J. Clin. Invest. 100(11): 2729-2736.
- Large, V., Peroni, O., Letexier, D., Ray, H., Beylot, M. 2004. Metabolism of lipids in human white adipocyte. Diabetes Metab. 30(4): 294-309.
- Lev-Yadun, S. 1997. Flora and climate in southern Samaria: past and present. In: Finkelstain, I., Llederman, Z., eds. Highlands of many cultures. The Institute of Archeology, Tel AViv University, Tel Aviv, pp. 85-102.
- Long, Y. C., Zierath, J. R. 2006. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116(7), 1776-1783.
- Perevolotsky, A., Pollak, G. 2000. Ecology: theory and the Israeli experience. Carta, Jerusalem, Israel, pp. 474-473 (in Hebrew).
- Rees, D. A., Alcolado, J. C. 2005. Animal models of diabetes mellitus. Diabetes Med. 22(4): 359-370.
- Saad, B., Azaizeh, H., Said, O. 2005. Tradition and perspectives of Arab herbal medicine. eCAM 2(4): 475-479.
- Shani, J., Joseph, B., Sulman, F. G. 1970. Fluctuations in the hypoglycaemic effect of Poterium spinosum L. (Rosaceae). Arch. Int. Pharmacodyn. Ther. 185(2): 344-349.
- Smyth, S., Heron, A. 2006. Diabetes and obesity: the twin epidemics. Nat. Med. 12(1): 75-80.
- Yaniv, Z., Dafni, A., Friedman, J., Palevitch, D. 1987. Plants used for the treatment of diabetes in Israel. J. Ethnopharmacol. 19(2): 145-151.
- Yildiz, B. O., Haznedaroglu, I. C. 2006. Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int. J. Biochem. Cell Biol. 38(5-6): 820-830.
- Yin, W., Mu, J., Birnbaum, M. J. 2003. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 278(44): 43074-43080.
- Zhao, Y. F., Feng, D. D., Chen, C. 2006. Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes. Int. J. Biochem. Cell Biol. 38(5-6): 804-819.
- Zohary, M., Feinbrun-Dothan, N. 1966. Flora Palaestina, part 4. Israel Academy of Science and Humanitites, Jerusalem, 136 pp.